One-year effectiveness and safety in young children aged 2-6 years with type 1 diabetes using an automated insulin delivery system: A real-world prospective cohort study
Diabetes Obes Metab. 2025 Oct 27. doi: 10.1111/dom.70228. Online ahead of print. ABSTRACT AIMS: This study evaluated 1-year real-world changes in glycaemic management, parent-reported outcomes …